Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 83

    1.

    Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention, and Screening--A Report From the American Society of Clinical Oncology.

    Petrelli NJ, Winer EP, Brahmer J, Dubey S, Smith S, Thomas C, Vahdat LT, Obel J, Vogelzang N, Markman M, Sweetenham JW, Pfister D, Kris MG, Schuchter LM, Sawaya R, Raghavan D, Ganz PA, Kramer B.

    J Clin Oncol. 2009 Nov 9. [Epub ahead of print] No abstract available. PMID: 19901123 [PubMed - as supplied by publisher]Related articles

    2.

    Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers.

    Carpenter EL, Mick R, Rech AJ, Beatty GL, Colligon TA, Rosenfeld MR, Kaplan DE, Chang KM, Domchek SM, Kanetsky PA, Fecher LA, Flaherty KT, Schuchter LM, Vonderheide RH.

    Clin Cancer Res. 2009 Jul 1;15(13):4277-87. Epub 2009 Jun 23.PMID: 19549767 [PubMed - indexed for MEDLINE]Related articles

    3.

    Drug targeting of oncogenic pathways in melanoma.

    Fecher LA, Amaravadi RK, Schuchter LM, Flaherty KT.

    Hematol Oncol Clin North Am. 2009 Jun;23(3):599-618, x. Review.PMID: 19464605 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.

    Winer E, Gralow J, Diller L, Karlan B, Loehrer P, Pierce L, Demetri G, Ganz P, Kramer B, Kris M, Markman M, Mayer R, Pfister D, Raghavan D, Ramsey S, Reaman G, Sandler H, Sawaya R, Schuchter L, Sweetenham J, Vahdat L, Schilsky RL; American Society of Clinical Oncology.

    J Clin Oncol. 2009 Feb 10;27(5):812-26. Epub 2008 Dec 22. Erratum in: J Clin Oncol. 2009 Jun 20;27(18):3070-1. PMID: 19103723 [PubMed - indexed for MEDLINE]Related articles

    5.

    American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.

    Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, Cohen GI, Emami B, Gradishar WJ, Mitchell RB, Thigpen JT, Trotti A 3rd, von Hoff D, Schuchter LM.

    J Clin Oncol. 2009 Jan 1;27(1):127-45. Epub 2008 Nov 17.PMID: 19018081 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effectively targeting BRAF in melanoma: a formidable challenge.

    Fecher LA, Amaravadi R, Schuchter LM.

    Pigment Cell Melanoma Res. 2008 Aug;21(4):410-1. No abstract available. PMID: 18710372 [PubMed - indexed for MEDLINE]Related articles

    7.

    A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel.

    Flaherty KT, Schiller J, Schuchter LM, Liu G, Tuveson DA, Redlinger M, Lathia C, Xia C, Petrenciuc O, Hingorani SR, Jacobetz MA, Van Belle PA, Elder D, Brose MS, Weber BL, Albertini MR, O'Dwyer PJ.

    Clin Cancer Res. 2008 Aug 1;14(15):4836-42.PMID: 18676756 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Meeting report: fourth international congress of the Society for Melanoma Research.

    Fisher DE, Medrano EE, McMahon M, Soengas MS, Schuchter L, Wolchok JD, Merlino G.

    Pigment Cell Melanoma Res. 2008 Feb;21(1):15-26.PMID: 18353140 [PubMed - indexed for MEDLINE]Related articles

    9.

    Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.

    Gralow J, Ozols RF, Bajorin DF, Cheson BD, Sandler HM, Winer EP, Bonner J, Demetri GD, Curran W Jr, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Ramsey S, Reaman GH, Sawaya R, Schuchter LM, Sweetenham JW, Vahdat LT, Davidson NE, Schilsky RL, Lichter AS; American Society of Clinical Oncology.

    J Clin Oncol. 2008 Jan 10;26(2):313-25. Epub 2007 Dec 17. Erratum in: J Clin Oncol. 2008 Mar 10;26(8):1394. PMID: 18086794 [PubMed - indexed for MEDLINE]Related articles

    10.

    Roadmap for new opportunities in melanoma research.

    Herlyn M, Halaban R, Ronai Z, Schuchter L, Berwick M, Pinkel D.

    Semin Oncol. 2007 Dec;34(6):566-76.PMID: 18083380 [PubMed - indexed for MEDLINE]Related articles

    11.

    Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillance.

    Domchek SM, Recio A, Mick R, Clark CE, Carpenter EL, Fox KR, DeMichele A, Schuchter LM, Leibowitz MS, Wexler MH, Vance BA, Beatty GL, Veloso E, Feldman MD, Vonderheide RH.

    Cancer Res. 2007 Nov 1;67(21):10546-55.PMID: 17974999 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.

    Swoboda RK, Somasundaram R, Caputo L, Ochoa EM, Gimotty PA, Marincola FM, Van Belle P, Barth S, Elder D, Guerry D, Czerniecki B, Schuchter L, Vonderheide RH, Herlyn D.

    Cancer Res. 2007 Apr 15;67(8):3555-9.PMID: 17440064 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.

    Gimotty PA, Elder DE, Fraker DL, Botbyl J, Sellers K, Elenitsas R, Ming ME, Schuchter L, Spitz FR, Czerniecki BJ, Guerry D.

    J Clin Oncol. 2007 Mar 20;25(9):1129-34.PMID: 17369575 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.

    Ozols RF, Herbst RS, Colson YL, Gralow J, Bonner J, Curran WJ Jr, Eisenberg BL, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Reaman GH, Sawaya R, Schilsky RL, Schuchter LM, Sweetenham JW, Vahdat LT, Winn RJ; American Society of Clinical Oncology.

    J Clin Oncol. 2007 Jan 1;25(1):146-62. Epub 2006 Dec 8.PMID: 17158528 [PubMed - indexed for MEDLINE]Related articles

    15.

    Preferential involvement of CX chemokine receptor 4 and CX chemokine ligand 12 in T-cell migration toward melanoma cells.

    Zhang T, Somasundaram R, Berking C, Caputo L, Van Belle P, Elder D, Czerniecki B, Hotz S, Schuchter L, Spitz FR, Berencsi K, Rani P, Marincola F, Qiu R, Herlyn D.

    Cancer Biol Ther. 2006 Oct;5(10):1304-12. Epub 2006 Oct 4.PMID: 16929176 [PubMed - indexed for MEDLINE]Related articles

    16.

    Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.

    Eisen T, Ahmad T, Flaherty KT, Gore M, Kaye S, Marais R, Gibbens I, Hackett S, James M, Schuchter LM, Nathanson KL, Xia C, Simantov R, Schwartz B, Poulin-Costello M, O'Dwyer PJ, Ratain MJ.

    Br J Cancer. 2006 Sep 4;95(5):581-6. Epub 2006 Aug 1.PMID: 16880785 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Repeat operative sentinel lymph node biopsy.

    Jackson BM, Kim S, Davidson R, Schuchter L, Acs G, Czerniecki BJ.

    Clin Breast Cancer. 2006 Feb;6(6):530-2.PMID: 16595037 [PubMed - indexed for MEDLINE]Related articles

    18.

    Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patients.

    Somasundaram R, Swoboda R, Caputo L, Otvos L, Weber B, Volpe P, van Belle P, Hotz S, Elder DE, Marincola FM, Schuchter L, Guerry D, Czerniecki BJ, Herlyn D.

    Cancer Res. 2006 Mar 15;66(6):3287-93.PMID: 16540682 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.

    Herbst RS, Bajorin DF, Bleiberg H, Blum D, Hao D, Johnson BE, Ozols RF, Demetri GD, Ganz PA, Kris MG, Levin B, Markman M, Raghavan D, Reaman GH, Sawaya R, Schuchter LM, Sweetenham JW, Vahdat LT, Vokes EE, Winn RJ, Mayer RJ; American Society of Clinical Oncology.

    J Clin Oncol. 2006 Jan 1;24(1):190-205. Epub 2005 Dec 2.PMID: 16326753 [PubMed - indexed for MEDLINE]Related articles

    20.

    Ethnic disparities in adjuvant chemotherapy for breast cancer are not caused by excess toxicity in black patients.

    Smith K, Wray L, Klein-Cabral M, Schuchter L, Fox K, Glick J, DeMichele A.

    Clin Breast Cancer. 2005 Aug;6(3):260-6; discussion 267-9.PMID: 16137438 [PubMed - indexed for MEDLINE]Related articles

    21.

    Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging.

    Gimotty PA, Guerry D, Ming ME, Elenitsas R, Xu X, Czerniecki B, Spitz F, Schuchter L, Elder D.

    J Clin Oncol. 2004 Sep 15;22(18):3668-76. Epub 2004 Aug 9. Erratum in: J Clin Oncol. 2005 Jan 20;23(3):656. PMID: 15302909 [PubMed - indexed for MEDLINE]Related articles

    22.

    Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?

    Fuster D, Chiang S, Johnson G, Schuchter LM, Zhuang H, Alavi A.

    J Nucl Med. 2004 Aug;45(8):1323-7.PMID: 15299056 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach.

    Kanetsky PA, Ge F, Najarian D, Swoyer J, Panossian S, Schuchter L, Holmes R, Guerry D, Rebbeck TR.

    Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):808-19.PMID: 15159314 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Psychosocial factors related to the correspondence of recipient and provider perceptions of social support among patients diagnosed with or at risk for malignant melanoma.

    Lichtenthal WG, Cruess DG, Schuchter LM, Ming ME.

    J Health Psychol. 2003 Nov;8(6):705-19.PMID: 14670205 [PubMed - indexed for MEDLINE]Related articles

    25.

    Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?

    Schuchter LM.

    J Clin Oncol. 2004 Jan 1;22(1):7-10. Epub 2003 Dec 9. No abstract available. PMID: 14665612 [PubMed - indexed for MEDLINE]Related articles

    26.

    Amifostine and chemoradiation therapy: ASCO responds.

    Schuchter L, Meropol NJ, Winer EP, Hensley ML, Somerfield MR; ASCO Chemotherapy and Radiotherapy Panel.

    Lancet Oncol. 2003 Oct;4(10):593. No abstract available. PMID: 14554234 [PubMed - indexed for MEDLINE]Related articles

    27.

    Retransplantation of a cardiac allograft inadvertently harvested from a donor with metastatic melanoma.

    Loren AW, Desai S, Gorman RC, Schuchter LM.

    Transplantation. 2003 Aug 27;76(4):741-3.PMID: 12973122 [PubMed - indexed for MEDLINE]Related articles

    28.

    Diagnosis and management of high-risk and metastatic melanoma.

    Hollis G, Recio A, Schuchter L.

    Semin Oncol Nurs. 2003 Feb;19(1):32-42. Review.PMID: 12638379 [PubMed - indexed for MEDLINE]Related articles

    29.

    Desmoplastic neurotropic melanoma of the head and neck: the role of radiation therapy.

    Anderson TD, Weber RS, Guerry D, Elder D, Schuchter L, Loevner LA, Rosenthal DI.

    Head Neck. 2002 Dec;24(12):1068-71.PMID: 12454945 [PubMed - indexed for MEDLINE]Related articles

    30.

    A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer.

    Miller KD, Gradishar W, Schuchter L, Sparano JA, Cobleigh M, Robert N, Rasmussen H, Sledge GW.

    Ann Oncol. 2002 Aug;13(8):1220-4.PMID: 12181245 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Phase I trial of the cryptophycin analogue LY355703 administered as an intravenous infusion on a day 1 and 8 schedule every 21 days.

    Stevenson JP, Sun W, Gallagher M, Johnson R, Vaughn D, Schuchter L, Algazy K, Hahn S, Enas N, Ellis D, Thornton D, O'Dwyer PJ.

    Clin Cancer Res. 2002 Aug;8(8):2524-9.PMID: 12171879 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    P gene as an inherited biomarker of human eye color.

    Rebbeck TR, Kanetsky PA, Walker AH, Holmes R, Halpern AC, Schuchter LM, Elder DE, Guerry D.

    Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):782-4.PMID: 12163334 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.

    Schuchter LM, Hensley ML, Meropol NJ, Winer EP; American Society of Clinical Oncology Chemotherapy and Radiotherapy Expert Panel.

    J Clin Oncol. 2002 Jun 15;20(12):2895-903. No abstract available. PMID: 12065567 [PubMed - indexed for MEDLINE]Related articles

    34.

    Metastatic melanoma.

    Sun W, Schuchter LM.

    Curr Treat Options Oncol. 2001 Jun;2(3):193-202. Review.PMID: 12057119 [PubMed - indexed for MEDLINE]Related articles

    35.

    Early stage (I, II, III) melanoma.

    Sondak VK, Ross MI, Schuchter LM.

    Curr Treat Options Oncol. 2001 Jun;2(3):183-91. Review.PMID: 12057118 [PubMed - indexed for MEDLINE]Related articles

    36.

    Pathology review of cases presenting to a multidisciplinary pigmented lesion clinic.

    McGinnis KS, Lessin SR, Elder DE, Guerry D 4th, Schuchter L, Ming M, Elenitsas R.

    Arch Dermatol. 2002 May;138(5):617-21.PMID: 12020222 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Multiple primary melanoma revisited.

    Blackwood MA, Holmes R, Synnestvedt M, Young M, George C, Yang H, Elder DE, Schuchter LM, Guerry D, Ganguly A.

    Cancer. 2002 Apr 15;94(8):2248-55.PMID: 12001124 [PubMed - indexed for MEDLINE]Related articles

    38.

    Cutaneous toxicities of cancer therapy.

    Alley E, Green R, Schuchter L.

    Curr Opin Oncol. 2002 Mar;14(2):212-6. Review.PMID: 11880713 [PubMed - indexed for MEDLINE]Related articles

    39.

    Review of the 2001 AJCC staging system for cutaneous malignant melanoma.

    Schuchter LM.

    Curr Oncol Rep. 2001 Jul;3(4):332-7. Review.PMID: 11389818 [PubMed - indexed for MEDLINE]Related articles

    40.

    Locally recurrent malignant melanoma characteristics and outcomes: a single-institution study.

    Wildemore JK 4th, Schuchter L, Mick R, Synnestvedt M, Elenitsas R, Bedrosian I, Czerniecki BJ, Guerry D 4th, Lessin SR, Elder DE, Bucky LP.

    Ann Plast Surg. 2001 May;46(5):488-94.PMID: 11352421 [PubMed - indexed for MEDLINE]Related articles

    41.

    The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience.

    Chang JH, Vines E, Bertsch H, Fraker DL, Czerniecki BJ, Rosato EF, Lawton T, Conant EF, Orel SG, Schuchter L, Fox KR, Zieber N, Glick JH, Solin LJ.

    Cancer. 2001 Apr 1;91(7):1231-7.PMID: 11283921 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Update in oncology.

    Schuchter LM, Haller DG.

    Ann Intern Med. 2000 Oct 17;133(8):615-21. Review. No abstract available. PMID: 11033591 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase.

    Bedrosian I, Faries MB, Guerry D 4th, Elenitsas R, Schuchter L, Mick R, Spitz FR, Bucky LP, Alavi A, Elder DE, Fraker DL, Czerniecki BJ.

    Ann Surg Oncol. 2000 May;7(4):262-7.PMID: 10819365 [PubMed - indexed for MEDLINE]Related articles

    44.

    Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer.

    Visonneau S, Cesano A, Porter DL, Luger SL, Schuchter L, Kamoun M, Torosian MH, Duffy K, Sickles C, Stadtmauer EA, Santoli D.

    Clin Cancer Res. 2000 May;6(5):1744-54.PMID: 10815893 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract.

    Schuchter LM, Green R, Fraker D.

    Curr Opin Oncol. 2000 Mar;12(2):181-5. Review.PMID: 10750731 [PubMed - indexed for MEDLINE]Related articles

    46.

    Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination.

    Stadtmauer EA, Tsai DE, Sickles CJ, Mick R, Luger SM, Porter DL, Mangan PA, Schuchter LM, Schuster SJ, Loh EY, Magee DA, Sachs RA, Wall ME, Moore J, Buzby GP, Zaleta E, Kamoun M, Silberstein LE.

    Med Oncol. 1999 Dec;16(4):279-88.PMID: 10618691 [PubMed - indexed for MEDLINE]Related articles

    47.

    Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.

    Chapman PB, Einhorn LH, Meyers ML, Saxman S, Destro AN, Panageas KS, Begg CB, Agarwala SS, Schuchter LM, Ernstoff MS, Houghton AN, Kirkwood JM.

    J Clin Oncol. 1999 Sep;17(9):2745-51.PMID: 10561349 [PubMed - indexed for MEDLINE]Related articles

    48.

    Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapy.

    Moore HC, Mick R, Solin LJ, Sickles C, Mangan PA, Luger SM, Fox KR, Schuchter LM, Loh E, Porter DL, Schuster S, Buzby GP, Glatstein E, Silberstein LE, Stadtmauer EA.

    Ann Oncol. 1999 Aug;10(8):929-36.PMID: 10509154 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.

    Hensley ML, Schuchter LM, Lindley C, Meropol NJ, Cohen GI, Broder G, Gradishar WJ, Green DM, Langdon RJ Jr, Mitchell RB, Negrin R, Szatrowski TP, Thigpen JT, Von Hoff D, Wasserman TH, Winer EP, Pfister DG.

    J Clin Oncol. 1999 Oct;17(10):3333-55.PMID: 10506637 [PubMed - indexed for MEDLINE]Related articles

    50.

    Breast MR imaging in patients with axillary node metastases and unknown primary malignancy.

    Orel SG, Weinstein SP, Schnall MD, Reynolds CA, Schuchter LM, Fraker DL, Solin LJ.

    Radiology. 1999 Aug;212(2):543-9.PMID: 10429716 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...